Evidence map›Paper›PMID 30307490›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016.

Mark G Thompson, Jeffrey C Kwong, Annette K Regan, Mark A Katz, Steven J Drews, Eduardo Azziz-Baumgartner, Nicola P Klein, Hannah Chung, Paul V Effler, Becca S Feldman and 12 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 4 pooled it
15.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 4 syntheses or guidelines pooled it, 183 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Journal of health communication · 2025
    Article
  18. Review
  19. The added value of serologic testing: A comparison of influenza incidence among pregnant persons based on molecular-based surveillance versus serologic testing.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2024
    Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 15 institutions in 5 countries.

Mark G ThompsonInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Jeffrey C KwongInstitute for Clinical Evaluative Sciences.
Annette K ReganSchool of Public Health, Curtin University, Perth.
Mark A KatzChief Physician's Office, Clalit Health Services, Clalit Research Institute, Tel Aviv.
Steven J DrewsUniversity of Alberta.
Eduardo Azziz-BaumgartnerInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Nicola P KleinKaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland.
Hannah ChungInstitute for Clinical Evaluative Sciences.
Paul V EfflerCommunicable Disease Control Directorate, Department of Health Western Australia, Perth, Australia.
Becca S FeldmanChief Physician's Office, Clalit Health Services, Clalit Research Institute, Tel Aviv.
Kimberley SimmondsCumming School of Medicine, University of Calgary.
Brandy E WyantAbt Associates, Cambridge, Massachusetts.
Fatimah S DawoodInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Michael L JacksonKaiser Permanente Washington Health Research Institute, Seattle, Washington.
Deshayne B FellInstitute for Clinical Evaluative Sciences.
Avram LevyDepartment of Microbiology, QEII Medical Centre, PathWest Laboratory Medicine, Nedlands, Western Australia, Australia.
Noam BardaChief Physician's Office, Clalit Health Services, Clalit Research Institute, Tel Aviv.
Lawrence W SvensonAlberta Health, Edmonton, Canada.
Rebecca V FinkAbt Associates, Cambridge, Massachusetts.
Sarah W BallAbt Associates, Cambridge, Massachusetts.
Allison NalewayCenter for Health Research, Kaiser Permanente Northwest, Portland, Oregon.
PREVENT Workgroup
Abt Global (United States) · USCenters for Disease Control and Prevention · USClalit Health Services · ILUniversity of Alberta · CABen-Gurion University of the Negev · ILGovernment of Western Australia Department of Health · AUInstitute for Clinical Evaluative Sciences · CAKaiser Permanente · USKaiser Permanente Center for Health Research · USKaiser Permanente Washington Health Research Institute · USQueen Elizabeth II Medical Centre · AUThe Kids Research Institute Australia · AUUniversity Health Network · CAUniversity of Calgary · CAUniversity of Ottawa · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo date, no study has examined influenza vaccine effectiveness (IVE) against laboratory-confirmed influenza-associated hospitalizations during pregnancy.

methodsThe Pregnancy Influenza Vaccine Effectiveness Network (PREVENT) consisted of public health or healthcare systems with integrated laboratory, medical, and vaccination records in Australia, Canada (Alberta and Ontario), Israel, and the United States (California, Oregon, and Washington). Sites identified pregnant women aged 18 through 50 years whose pregnancies overlapped with local influenza seasons from 2010 through 2016. Administrative data were used to identify hospitalizations with acute respiratory or febrile illness (ARFI) and clinician-ordered real-time reverse transcription polymerase chain reaction (rRT-PCR) testing for influenza viruses. Overall IVE was estimated using the test-negative design and adjusting for site, season, season timing, and high-risk medical conditions.

resultsAmong 19450 hospitalizations with an ARFI discharge diagnosis (across 25 site-specific study seasons), only 1030 (6%) of the pregnant women were tested for influenza viruses by rRT-PCR. Approximately half of these women had pneumonia or influenza discharge diagnoses (54%). Influenza A or B virus infections were detected in 598/1030 (58%) of the ARFI hospitalizations with influenza testing. Across sites and seasons, 13% of rRT-PCR-confirmed influenza-positive pregnant women were vaccinated compared with 22% of influenza-negative pregnant women; the adjusted overall IVE was 40% (95% confidence interval = 12%-59%) against influenza-associated hospitalization during pregnancy.

conclusionBetween 2010 and 2016, influenza vaccines offered moderate protection against laboratory-confirmed influenza-associated hospitalizations during pregnancy, which may further inform the benefits of maternal influenza vaccination programs.

Indexed as

Vaccine PotencyAdolescentAdultAustraliaCanadaFemaleHospitalizationHumansImmunogenicity, VaccineInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza B virusInfluenza, HumanInfluenza VaccinesMiddle AgedPregnancyInfluenza VaccinesRNA, Viralhospitalizationinfluenzapregnancypregnant womenvaccine effectiveness

Identifiers

PMID30307490
OpenAlexW2897893390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.